Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
卡博特韦用于预防女性 HIV-1 感染:一项 3 期随机临床试验 HPTN 084 的结果
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(22)00538-4
Delany-Moretlwe, Sinead; Hughes, James P; Bock, Peter; Ouma, Samuel Gurrion; Hunidzarira, Portia; Kalonji, Dishiki; Kayange, Noel; Makhema, Joseph; Mandima, Patricia; Mathew, Carrie; Spooner, Elizabeth; Mpendo, Juliet; Mukwekwerere, Pamela; Mgodi, Nyaradzo; Ntege, Patricia Nahirya; Nair, Gonasagrie; Nakabiito, Clemensia; Nuwagaba-Biribonwoha, Harriet; Panchia, Ravindre; Singh, Nishanta; Siziba, Bekezela; Farrior, Jennifer; Rose, Scott; Anderson, Peter L; Eshleman, Susan H; Marzinke, Mark A; Hendrix, Craig W; Beigel-Orme, Stephanie; Hosek, Sybil; Tolley, Elizabeth; Sista, Nirupama; Adeyeye, Adeola; Rooney, James F; Rinehart, Alex; Spreen, William R; Smith, Kimberly; Hanscom, Brett; Cohen, Myron S; Hosseinipour, Mina C